Table 1.
Group | BUN (mg/dl) | Creatinine (mg/dl) |
I | 34.68±0.18f | 0.59±0.01d |
II | 31.32±0.41e | 0.64±0.02d |
III | 43.22±0.53d | 0.72±0.01d |
IV | 79.88±0.33a | 4.81±0.03a |
V | 48.03±1.66c | 1.72±0.05c |
VI | 73.02±0.56b | 3.43±0.18b |
| ||
P | *** | *** |
Group I: control group; Group II: HPE1-administered group; Group III: HPE2-administered group; Group IV: gentamicin-administered group; Group V: gentamicin-plus-HPE1-treated group; Group VI: gentamicin-plus-HPE2-treated group. Data are expressed as mean±SEM (n=6). Values with different superscripts within one column differ significantly.
P<0.001